On 3 March 2026 (15:00 CET), this IAS–IAVI Timely Topic Webinar will bring together global stakeholders to discuss the f...
On 3 March 2026 (15:00 CET), this IAS–IAVI Timely Topic Webinar will bring together global stakeholders to discuss the future of HIV vaccine research in a shifting funding landscape.
Despite significant progress in HIV prevention and treatment, persistent inequities, emerging drug resistance, and recent global funding cuts continue to threaten advances — underscoring the urgent need for an effective HIV vaccine.
The session will explore how innovative multi-stakeholder partnerships — spanning governments, funders, African research institutions, and communities — can sustain and strengthen HIV vaccine R&D. Speakers will highlight successful partnership models, key funding and governance lessons, and strategies to advance African-led leadership and long-term investment in the next generation of HIV vaccines.
Participants will also learn how collaborative approaches can transform current challenges into opportunities for resilient, equitable research systems. 🤝
On 3 March 2026 (15:00 CET), this IAS–IAVI Timely Topic Webinar will bring together global stakeholders to discuss the future of HIV vaccine research in a shifting funding landscape.
Despite significant progress in HIV prevention and treatment, persistent inequities, emerging drug resistance, an...
On 3 March 2026 (15:00 CET), this IAS–IAVI Timely Topic Webinar will bring together global stakeholders to discuss the future of HIV vaccine research in a shifting funding landscape.
Despite significant progress in HIV prevention and treatment, persistent inequities, emerging drug resistance, and recent global funding cuts continue to threaten advances — underscoring the urgent need for an effective HIV vaccine.
The session will explore how innovative multi-stakeholder partnerships — spanning governments, funders, African research institutions, and communities — can sustain and strengthen HIV vaccine R&D. Speakers will highlight successful partnership models, key funding and governance lessons, and strategies to advance African-led leadership and long-term investment in the next generation of HIV vaccines.
Participants will also learn how collaborative approaches can transform current challenges into opportunities for resilient, equitable research systems. 🤝
DE 
EN 
